Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting

Journal of Clinical Microbiology

Volumn 34, Issue 12, 1996, Pages 2914-2920

  Mahenthiralingam, Eshwar ^a,c   Campbell, Maureen E ^a   Henry, Deborah A ^a   Speert, David P ^a,b  

^a Canadian Bacterial Diseases Network   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Gerontology Research Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA POLYMORPHISM; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING;

BURKHOLDERIA; BURKHOLDERIA CEPACIA; NEGIBACTERIA;

EID: 0029910333     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.12.2914-2920.1996     Document Type: Article

References (31)

1. Akopyanz, N., N. O. Bukanov, T. U. Westblom, S. Kresovich, and D. E. Berg. 1992. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 20:5137-5142.
2. Bingen, E. D., M. O. Weber, J. Derelle, N. Brahimi, N. Y. Lambert-Zechoovsky, M. Vidailhet, J. Navarro, and J. Elion. 1993. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J. Clin. Microbiol. 31:2589-2593.
3. Burdge, D. R., M. A. Noble, M. E. Campbell, V. L. Krell, and D. P. Speert, 1995. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20:445-448.
4. Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
5. di Sant'Agnese, P. A., and P. B. Davis. 1976. Research in cystic fibrosis. N. Engl. J. Med. 295:597-602.
6. Govan, J. R. W. 1995. Burkholderia cepacia in cystic fibrosis. N. Engl. J. Med. 332:819-820.
7. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:35-9.
8. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
9. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
10. Kersulyte, D., M. J. Struelens, A. Deplano, and D. E. Berg. 1995. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J. Clin. Microbiol. 33:2216-2219.
11. Kostman, J. R., T. D. Edlind, J. J. LiPuma, and T. L. Stull. 1992. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J. Clin. Microbiol. 30:2084-2087.
12. Larsen, G. Y., T. L. Stull, and J. L. Burns. 1993. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J. Clin. Microbiol. 31:788-792.
13. LiPuma, J. J., S. E. Dasen, D. W. Nielson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
14. LiPuma, J. J., M. C. Fischer, S. E. Dasen, J. E. Mortenson, and T. L. Stull. 1991. Ribotype stability of isolates ai Pseudomonas cepacia. J. Infect. Dis. 164:133-136.
15. LiPuma, J. J., J. E. Mortensen, S. E. Dasen, T. D. Edlind, D. V. Schidlow, J. L. Burns, and T. L. Stull. 1988. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis centers. J. Pediatr. 113:859-862.
16. LiPuma, J. J., and T. L. Stull. 1995. Burkholderia cepacia in cystic fibrosis. N. Engl. J. Med. 332:820-821.
17. Liu, P. Y.-K., Z.-Y. Shi, Y.-J. Lau, B.-S. Hu, J.-M. Shyr, W.-S. Tsai, Y.-H. Lin, and C.-Y. Tseng. 1995. Comparison of different PCR approaches for the characterization of Burkholderia (Pseudomonas) cepacia isolates. J. Clin. Microbiol. 33:3304-3307.
18. Mahenthiralingam, E. Unpublished data.
19. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudumonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
20. Mahenthiralingam, E., M. E. Campbell, D. A. Henry, and D. P. Speert. 1995. Molecular epidemiology of Burkholderia cepacia using random amplified polymorphic DNA (RAPD) analysis, abstr. S17.4, p. 164-165. In Program and abstracts of the Ninth Annual North American Cystic Fibrosis Conference. Pediatric pulmonology, suppl. 12. Willey-Liss, New York.
21. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1995. Burkholderia cepacia in cystic fibrosis. N. Engl. J. Med. 332:819.
22. Pegues, D. A., L. A. Carson, O. C. Tablan, S. C. FitzSimmons, S. B. Roman, J. M. Miller, W. R. Jarvis, and the Summer Camp Study Group. 1994. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J. Pediatr. 124:694-702.
23. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 188:830-834.
24. Rabkin, C. S., W. R. Jarvis, R. L. Anderson, J. Govan, J. Klinger, J. J. LiPuma, W. J. Martone, H. Montell, C. Richard, S. Shigeta, A. Sosa, T. Stull, J. Swenson, and D. Woods. 1989. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev. Infect. Dis. 11:600-607.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Smith, D. L., L. B. Gumery, E. G. Smith, D. E. Stableforth, M. E. Kaufmann, and T. L. Pitt. 1993. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person spread. J. Clin. Microbiol. 31: 3017-3022.
27. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-235. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeruginosa infections and treatment. Marcel Dekker, Inc., New York.
28. Steinbach, S., L. Sun, R.-Z. Jiang, P. Flume, P. Gilligan, T. M. Egan, and R. Goldstein. 1994. Pseudomonas cepacia in cystic fibrosis lung transplant recipients and clinic patients. N. Engl. J. Med. 331:981-987.
29. Stull, T. L., J. J. LiPuma, and T. D. Edlind. 1988. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J. Infect. Dis. 157: 280-285.
30. + Pseudomonas (Burkholderia) cepacia causing epidemics in North America and Britain. Nat. Med. 1:661-666.
31. Tablan, O. C., T. L. Chorba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Chow, W. J. Martone, and W. R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.